|
BUYINS.NET: BE, EAG, NGD, ABPI, EVVV, GAIN Have Been Removed From
Naked Short List Today
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:18072008
BUYINS.NET, www.buyins.net, announced today that these select companies
have been removed from the NASDAQ, AMEX and NYSE naked short threshold
list: BearingPoint Inc. (NYSE: BE), American Defense Systems Inc (AMEX:
EAG), New Gold Inc (AMEX: NGD), Accentia Biopharmaceuticals Inc.
(NASDAQ: ABPI), ev3 Inc. (NASDAQ: EVVV), Gladstone Investment Corp.
(NASDAQ: GAIN). For a complete list of companies on the naked short
list please visit our web site. To find the SqueezeTrigger Price before
a short squeeze starts in any stock, go to www.buyins.net.
BearingPoint Inc. (NYSE: BE) provides management and technology
consulting services primarily in North America and internationally. The
company offers management consulting, technology solutions, application
services, and managed services. Its integration services comprise
designing, building, and implementing new or enhanced system
applications and related processes; general business consulting
services include system selection or assessment, feasibility studies,
business valuations, and corporate strategy; and managed services
consist of managing, staffing, maintaining, hosting, or otherwise
running solutions and systems provided to its customers. The company
serves agencies of the U.S. federal government, such as the departments
of defense, homeland security, and health and human services;
provincial, state, and local governments; public healthcare companies
and private sector healthcare agencies; aerospace and defense
companies; and higher education clients, as well as various sectors,
including technology, consumer markets, manufacturing, life sciences,
energy markets, transportation, communications, and private and public
utilities. BearingPoint also provides solutions to banking, insurance,
securities, real estate, hospitality, and professional services
institutions. The company was founded in 1999. It was formerly known as
KPMG Consulting, Inc. and changed its name to BearingPoint, Inc. in
2002. The company is headquartered in McLean, Virginia. With 217.9
million shares outstanding and 31.13 million shares declared short as
of July 2008, there is no longer a failure to deliver in shares of BE.
According to quarterly data provided by the SEC, there were still
169,401 shares of BE that were failing-to-deliver as of September 13,
2007.
American Defense Systems Inc (AMEX: EAG) provides customized
transparent and opaque armor solutions for tactical and non-tactical
transport vehicles and construction equipment used by the military in
the United States. It engages in the research and development, design
and engineering, fabrication, and component integration; and provides
subject matter experts in engineering, ballistics, government
contracts, program management, and logistics. The company's products
include crew protection kits for armor protection of operator
compartments; VistaSteel transparent armor that provides a defensive
barrier to protect against firearms, physical attack, and explosive
blasts; VistaSteel opaque armor installed on various military vehicles
to form up-armor or add-on armor kits; VistaGuard windows, which are
forced entry blast resistant windows, window frames, and transparent
armor assemblies used to mitigate forced entry, ballistic, and
terrorist threats; forced entry blast resistant curtain wall; mobile
ballistic shield, a bullet-resistant transparent mobile shield used in
hostage negotiation and other hostile situations; and trans-barrier
system, a transparent armor shield to provide ballistic and blast
protection. ADSI also offers heated ballistic ships' windows;
proprietary hardware, including hinges, rotary and slam latch, combat
lock, and egress window; T2 ballistic range, a live fire interactive
training range system to provide training to war fighters or law
enforcement personnel; handheld, lightweight police shields; and
lightweight combat helmet with ballistic resistance. The company serves
military, government, law enforcement, detention and security industry,
and correctional agencies, as well as private sector. It also operates
a retail outlet carrying body armor, tactical nylon products, weapons,
ammunition, weapons parts and accessories, and other tactical gear.
American Defense Systems, Inc. was founded in 1994 and is headquartered
in Hicksville, New York. With 39.34 million shares outstanding and
17,200 shares declared short as of July 2008, there is no longer a
failure to deliver in shares of EAG.
New Gold Inc (AMEX: NGD) engages in the acquisition and mining of
mineral properties. It primarily focuses on gold, copper, and silver
deposits. The company's assets portfolio is located in Canada, Chile,
Mexico, Brazil, Australia, and Alaska. New Gold, Inc. is based in
Vancouver, Canada. With 36.95 million shares outstanding and 3.75
million shares declared short as of July 2008, there is no longer a
failure to deliver in shares of NGD. According to quarterly data
provided by the SEC, there were still 28,032 shares of NGD that were
failing-to-deliver as of August 22, 2007.
Accentia Biopharmaceuticals Inc. (NASDAQ: ABPI) a biopharmaceutical
company, together with its subsidiaries, develops and commercializes
drug candidates that are in late-stage clinical development based on
active pharmaceutical ingredients in the therapeutic areas of
respiratory disease and oncology. It operates in two segments:
Biopharmaceutical Products and Services, and Specialty Pharmaceuticals.
The Biopharmaceutical Products and Services segment develops late-stage
biopharmaceutical products. Its products, which are under Phase III
clinical trials, include SinuNase for the treatment of chronic
rhinosinusitis; BiovaxID, a patient-specific anti-cancer vaccine
focusing on the treatment of follicular non-Hodgkins lymphoma; and
Revimmune for the treatment of multiple sclerosis, an autoimmune
disease that affects the central nervous system, and various autoimmune
diseases, including systemic lupus, myasthenia gravis, and aplastic
anemia. This segment also provides various consulting services relating
to biopharmaceutical product development; and engages in the production
of custom biologic products and cell culture instruments and systems
for biopharmaceutical and biotechnology companies, medical schools,
universities, hospitals, and research institutions. The Specialty
Pharmaceuticals segment markets and sells pharmaceutical products that
are developed primarily by third-party development partners. Its
products comprise Respi-TANN, a prescription antitussive decongestant
for temporary relief of cough and nasal congestion; SinuTest, a test
used in connection with the diagnosis of chronic sinusitis; and
Zinotic, a treatment of superficial infections of the external ear.
This segment's products under development include AllerNase, a
formulated suspension of an intranasal topical steroid indicated for
the treatment of allergic and non-allergic rhinitis; and Emezine, a
product for control of nausea and vomiting. The company was founded in
2002 and is headquartered in Tampa, Florida. With 45.23 million shares
outstanding and 2 million shares declared short as of July 2008, there
is no longer a failure to deliver in shares of ABPI. According to
quarterly data provided by the SEC, there were still 121,208 shares of
ABPI that were failing-to-deliver as of September 28, 2007.
ev3 Inc. (NASDAQ: EVVV) a medical device company, focuses on
catheter-based technologies for the endovascular treatment of vascular
diseases and disorders. It develops, manufactures, and markets a range
of products that include stents, atherectomy and thrombectomy products,
balloon angioplasty catheters, microcatheters and occlusion balloon
systems, embolic protection devices, infusion catheters/wires, embolic
coils, and liquid embolics. The company markets its products in the
United States, Europe, and Canada through a direct sales force, and
through distributors in the United States and international markets.
ev3, Inc. has a research collaboration with Merck & Co., Inc. for the
analysis of atherosclerotic plaque removed from patient arteries with
the goal of identifying new biomarkers of atherosclerotic disease
progression and new therapies for atherosclerotic disease. The company
is headquartered in Plymouth, Minnesota. With 105.22 million shares
outstanding and 10.73 million shares declared short as of July 2008,
there is no longer a failure to deliver in shares of EVVV. According to
quarterly data provided by the SEC, there were still 31,556 shares of
EVVV that were failing-to-deliver as of September 27, 2007.
Gladstone Investment Corp. (NASDAQ: GAIN) is a public investment firm
specializing in buyouts and recapitalizations. It seeks to make debt
and equity investments in small and mid-sized private businesses. The
firm invests in junior subordinated loans, mezzanine debt, preferred
stock, and warrants to purchase common stock of U.S. based companies.
It can also invest in senior secured loans and common stock. The firm
prefers to invest between $3 million and $20 million. It invests
individually as well as jointly with other buyout funds. The firm is
treated as a business development company under the 1940 Act. Gladstone
Management Corporation serves as the investment adviser of the firm. It
was founded in February 2005 and is based in McLean, Virginia.
Gladstone Investment Corporation operates as a subsidiary of The
Gladstone Companies. With 16.56 million shares outstanding and 127,500
shares declared short as of July 2008, there is no longer a failure to
deliver in shares of GAIN. According to quarterly data provided by the
SEC, there were still 10,596 shares of GAIN that were
failing-to-deliver as of August 8, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of
publicly traded US companies fight naked short selling. Naked short
selling is the illegal act of short selling a stock when no affirmative
determination has been made to locate shares of the stock to
hypothecate in connection with the short sale. Buyins.net has built a
proprietary database that uses Threshold list feeds from NASDAQ, AMEX
and NYSE to generate detailed and useful information to combat the
naked short selling problem. For the first time, actual trade by trade
data is available to the public that shows the attempted size, actual
size, price and average value of short sales in stocks that have been
shorted and naked shorted. This information is valuable in determining
the precise point at which short sellers go out-of-the-money and start
losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and
publishes a proprietary SqueezeTrigger for each stock that has been
shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database
of nearly 2,050,000,000 short sale transactions goes back to January 1,
2005, and calculates the exact price at which the Total Short Interest
is short in each stock. This data was never before available prior to
January 1, 2005, because the Self Regulatory Organizations (primary
exchanges) guarded it aggressively. After the SEC passed Regulation
SHO, exchanges were forced to allow data processors like Buyins.net to
access the data.
The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, BUYINS.NET provides institutions,
traders, analysts, journalists and individual investors the exact price
point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information
believed to be reliable. The information contained herein is not
guaranteed by BUYINS.NET to be accurate, and should not be considered
to be all-inclusive. The companies that are discussed in this opinion
have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. BUYINS.NET is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. BUYINS.NET may receive
compensation in cash or shares from independent third parties or from
the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. Market commentary provided by
Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not
and will not offer any opinion as to when others should sell; each
investor must make that decision based on his or her judgment of the
market.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and BUYINS.NET undertakes no obligation to update
such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
TMCnet LOGIN
Webinars
